Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA‐dependent protein kinase PKR
暂无分享,去创建一个
K. Jeang | C. Samuel | A. Gatignol | M. Benkirane | C. Neuveut | K T Jeang | A Gatignol | R. Chun | M Benkirane | S M Smith | C E Samuel | C Neuveut | R F Chun | Stephen M. Smith | C. E. Samuel
[1] N. Sonenberg,et al. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[2] R. Kaufman,et al. Expression of mutant eukaryotic initiation factor 2 alpha subunit (eIF-2 alpha) reduces inhibition of guanine nucleotide exchange activity of eIF-2B mediated by eIF-2 alpha phosphorylation , 1994, Molecular and cellular biology.
[3] B. Williams,et al. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. , 1994, Virology.
[4] B. Williams,et al. Transcriptional regulation of interferon-stimulated genes. , 1991, European journal of biochemistry.
[5] T. Mak,et al. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. , 1995, Virology.
[6] B. Jacobs,et al. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[7] K. Jeang,et al. Reduction in growth temperature minimizes instability of large plasmids containing HIV-1 proviral genomes. , 1993, BioTechniques.
[8] Michael B. Mathews,et al. A mechanism for the control of protein synthesis by adenovirus VA RNAI , 1986, Cell.
[9] E. Coccia,et al. Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment. , 1994, The Journal of biological chemistry.
[10] C. Samuel,et al. Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2 alpha protein kinase from human cells. , 1992, Virology.
[11] M. Katze,et al. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth , 1992, Journal of Virology.
[12] A. Aguzzi,et al. Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.
[13] I. Kerr,et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.
[14] P. Lengyel. Tumor-suppressor genes: news about the interferon connection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Katze,et al. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[16] K. Jeang,et al. Genetic mapping in human and mouse of the locus encoding TRBP, a protein that binds the TAR region of the human immunodeficiency virus (HIV-1). , 1995, Genomics.
[17] A. Hovanessian. The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. , 1989, Journal of interferon research.
[18] M. Katze,et al. Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. , 1992, The Journal of biological chemistry.
[19] K. Jeang,et al. Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[20] D. Faller,et al. Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2 alpha-kinase activation. , 1992, The Journal of biological chemistry.
[21] M. Katze,et al. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins. , 1995, Virology.
[22] C. Samuel,et al. Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Petryshyn,et al. Mechanism of action of a cellular inhibitor of the dsRNA-dependent protein kinase from 3T3-F442A cells. , 1992, The Journal of biological chemistry.
[24] M. Katze,et al. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation , 1995, Molecular and cellular biology.
[25] R. Panniers,et al. The catalytic mechanism of guanine nucleotide exchange factor action and competitive inhibition by phosphorylated eukaryotic initiation factor 2. , 1988, The Journal of biological chemistry.
[26] C. Samuel,et al. The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. , 1993, The Journal of biological chemistry.
[27] O. Elroy-Stein,et al. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2 , 1992, Journal of virology.
[28] C. Samuel,et al. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase , 1986, Cell.
[29] K. Jeang,et al. Expression of TAR RNA-Binding Protein in Baculovirus and Co-Immunoprecipitation with Insect Cell Protein Kinase. , 1995, Journal of biomedical science.
[30] A. Hovanessian,et al. Modified subcellular localization of interferon-induced p68 kinase during encephalomyocarditis virus infection. , 1990, Virology.
[31] Aseem Kumar,et al. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[32] W. Toone,et al. Mutational Analysis of the Double-stranded RNA (dsRNA) Binding Domain of the dsRNA-activated Protein Kinase, PKR (*) , 1995, The Journal of Biological Chemistry.
[33] S. B. Lee,et al. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. , 1994, Virology.
[34] R. Kaufman,et al. Control of gene expression at the level of translation initiation. , 1994, Current opinion in biotechnology.
[35] N. Sonenberg,et al. Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: A novel translational control mechanism , 1989, Cell.
[36] B. Berkhout,et al. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. , 1991, Science.
[37] P. Whitaker-Dowling,et al. Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase. , 1984, Virology.
[38] S. Der,et al. Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[39] H. Gendelman,et al. Interferons in the persistence, pathogenesis, and treatment of HIV infection. , 1992, AIDS research and human retroviruses.
[40] C. Samuel,et al. Mechanism of interferon action: autoregulation of RNA-dependent P1/eIF-2 alpha protein kinase (PKR) expression in transfected mammalian cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[41] P. Pitha. Multiple effects of interferon on the replication of human immunodeficiency virus type 1. , 1994, Antiviral research.
[42] I. London,et al. Growth-related expression of a double-stranded RNA-dependent protein kinase in 3T3 cells. , 1984, The Journal of biological chemistry.
[43] R. Silverman,et al. Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. , 1989, Nucleic acids research.
[44] M. Katze,et al. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. , 1992, Science.
[45] K. Jeang,et al. Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen , 1993, Molecular and cellular biology.
[46] H. Gendelman,et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.
[47] M. Katze,et al. Mammalian eukaryotic initiation factor 2 alpha kinases functionally substitute for GCN2 protein kinase in the GCN4 translational control mechanism of yeast. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[48] I. London,et al. Cloning of the cDNA of the heme-regulated eukaryotic initiation factor 2 alpha (eIF-2 alpha) kinase of rabbit reticulocytes: homology to yeast GCN2 protein kinase and human double-stranded-RNA-dependent eIF-2 alpha kinase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[49] N. Sonenberg. Measures and countermeasures in the modulation of initiation factor activities by viruses. , 1990, The New biologist.
[50] M. Esteban,et al. The interferon-induced double-stranded RNA-activated human p68 protein kinase potently inhibits protein synthesis in cultured cells. , 1993, Virology.
[51] B. Williams,et al. The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Weinstein,et al. In-Vitro Resistance to Zidovudine and Alpha-interferon in HIV-1 Isolates from Patients: Correlations with Treatment Duration and Response , 1992, Annals of Internal Medicine.
[53] C. Samuel,et al. Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity. , 1994, Virology.
[54] M. Katze,et al. The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[55] C. Samuel,et al. Mechanism of interferon action: RNA-binding activity of full-length and R-domain forms of the RNA-dependent protein kinase PKR--determination of KD values for VAI and TAR RNAs. , 1995, Virology.
[56] C. Samuel,et al. Mechanism of Interferon Action: Biochemical and Genetic Evidence for the Intermolecular Association of the RNA-Dependent Protein Kinase PKR from Human Cells , 1996 .
[57] C. Samuel,et al. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. , 1991, Virology.
[58] C. Samuel,et al. Mechanism of interferon action: inhibition of pppA(2'p5'A)n-dependent ribonucleases activity in micrococcal nuclease-treated mouse L cell-free extracts. , 1981, Biochemical and biophysical research communications.
[59] K. Jeang,et al. Human immunodeficiency viruses regulated by alternative trans‐activators: genetic evidence for a novel non‐transcriptional function of Tat in virion infectivity. , 1994, The EMBO journal.
[60] M. Katze,et al. The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation , 1989, Journal of virology.
[61] M. Katze,et al. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[62] N. Sonenberg,et al. Abrogation of translation initiation factor eIF‐2 phosphorylation causes malignant transformation of NIH 3T3 cells. , 1995, The EMBO journal.
[63] J. Hershey,et al. Translational control in mammalian cells. , 1991, Annual review of biochemistry.
[64] M. Katze,et al. The war against the interferon-induced dsRNA-activated protein kinase: can viruses win? , 1992, Journal of interferon research.
[65] C. Samuel,et al. Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase. , 1992, Virology.
[66] M. Katze,et al. Cellular inhibitors of the interferon-induced, dsRNA-activated protein kinase. , 1994, Progress in molecular and subcellular biology.
[67] I. London,et al. Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[68] T. Hunter,et al. Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling , 1995, Cell.
[69] N. Sonenberg. Translation factors as effectors of cell growth and tumorigenesis. , 1993, Current opinion in cell biology.
[70] M. Katze,et al. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins , 1994, Molecular and cellular biology.
[71] K. Schappert,et al. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. , 1992, The EMBO journal.
[72] E. Paoletti,et al. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[73] M. Clemens. 5 Protein Kinases That Phosphorylate eIF2 and eIF2B, and Their Role in Eukaryotic Cell Translational Control , 1996 .
[74] E. Meurs,et al. Rapid decrease in the levels of the double-stranded RNA-dependent protein kinase during virus infections. , 1987, Virology.
[75] K. Jeang,et al. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor , 1993, Journal of virology.